Publicaciones (36) Publicaciones de CONCEPCION MORA GIRAL

2023

  1. Mutual modulation of gut microbiota and the immune system in type 1 diabetes models

    Nature Communications, Vol. 14, Núm. 1

  2. NOD mouse dorsal root ganglia display morphological and gene expression defects before and during autoimmune diabetes development

    Frontiers in Endocrinology, Vol. 14

  3. PKN1 Kinase: A Key Player in Adipocyte Differentiation and Glucose Metabolism

    Nutrients, Vol. 15, Núm. 10

2021

  1. CDK11 Promotes Cytokine-Induced Apoptosis in Pancreatic Beta Cells Independently of Glucose Concentration and Is Regulated by Inflammation in the NOD Mouse Model

    Frontiers in Immunology, Vol. 12

  2. Toxicological Evaluations in Macrophages and Mice Acutely and Chronically Exposed to Halloysite Clay Nanotubes Functionalized with Polystyrene

    ACS Omega, Vol. 6, Núm. 44, pp. 29882-29892

2019

  1. B-Lymphocyte Phenotype Determines T-Lymphocyte Subset Differentiation in Autoimmune Diabetes

    Frontiers in immunology, Vol. 10, pp. 1732

2018

  1. Treatment of T1D via optimized expansion of antigen-specific Tregs induced by IL-2/anti-IL-2 monoclonal antibody complexes and peptide/MHC tetramers

    Scientific Reports, Vol. 8, Núm. 1

2016

  1. B-cell anergy induces a Th17 shift in a novel B lymphocyte transgenic NOD mouse model, the 116C-NOD mouse

    European Journal of Immunology, Vol. 46, Núm. 3, pp. 593-608

  2. LoVo colon cancer cells resistant to oxaliplatin overexpress c-MET and VEGFR-1 and respond to VEGF with dephosphorylation of c-MET

    Molecular Carcinogenesis, Vol. 55, Núm. 5, pp. 411-419

2014

  1. Cyclin D3 promotes pancreatic β-cell fitness and viability in a cell cycle-independent manner and is targeted in autoimmune diabetes

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 111, Núm. 33

  2. In vivo detection of peripherin-specific autoreactive B cells during type 1 diabetes pathogenesis

    Journal of Immunology, Vol. 192, Núm. 7, pp. 3080-3090

2013

  1. Cholera toxin subunit B peptide fusion proteins reveal impaired oral tolerance induction in diabetes-prone but not in diabetes-resistant mice

    European Journal of Immunology, Vol. 43, Núm. 11, pp. 2969-2979

2012

  1. The sole presence of CDK4 is not a solid criterion for discriminating between tumor and healthy pancreatic tissues

    International Journal of Cancer

2011

  1. In vivo diabetogenic action of CD4+ T lymphocytes requires Fas expression and is independent of IL-1 and IL-18

    European Journal of Immunology, Vol. 41, Núm. 5, pp. 1344-1351

  2. PCR-based microsatellite analysis to accelerate diabetogenic genetic background acquisition in transgenic mice

    Inmunologia, Vol. 30, Núm. 1, pp. 2-7

  3. Targeting of a T cell agonist peptide to lysosomes by DNA vaccination induces tolerance in the nonobese diabetic mouse

    Journal of Immunology, Vol. 186, Núm. 7, pp. 4078-4087

2008

  1. Cyclin-dependent kinase 4 hyperactivity promotes autoreactivity in the immune system but protects pancreatic β cell mass from autoimmune destruction in the nonobese diabetic mouse model

    Journal of Immunology, Vol. 180, Núm. 2, pp. 1189-1198

2005

  1. Development of autoreactive diabetogenic T cells in the thymus of NOD mice

    Journal of Autoimmunity, Vol. 24, Núm. 1, pp. 11-23

2004

  1. Pancreatic islets from cyclin-dependent kinase 4/R24C (Cdk4) knockin mice have significantly increased beta cell mass and are physiologically functional, indicating that Cdk4 is a potential target for pancreatic beta cell mass regeneration in Type 1 diabetes

    Diabetologia, Vol. 47, Núm. 4, pp. 686-694

  2. Role of L-selectin in the development of autoimmune diabetes in non-obese diabetic mice

    International Immunology, Vol. 16, Núm. 2, pp. 257-264